Literature DB >> 25840770

Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.

Shih-Hsiang Chen1, Tsung-Yen Chang, Tang-Her Jaing, Mel S Lee, Chao-Jan Wang, Iou-Jih Hung, Chao-Ping Yang.   

Abstract

Osteonecrosis (ON) is a potentially disabling complication encountered in children who receive chemotherapy for acute lymphoblastic leukemia (ALL). Considering the possible effect of ethnic difference on the clinical features of symptomatic ON in pediatric ALL, we retrospectively evaluated 245 children with ALL who were treated at Chang Gung Memorial Hospital, Linkou, between 2002 and 2011. Six (2.4 %) patients developed symptomatic ON in a total of 17 sites during the follow-up period. Diagnosis of ON was confirmed by X-ray in seven, magnetic resonance imaging in two, and bone scan in three patients. The estimated cumulative incidence of symptomatic ON in newly diagnosed ALL was 3.4 % at 8 years. Four patients received ON-directed surgical interventions, including total hip replacement in three and arthroplasty in one. The incidence of ON was significantly higher among girls (P = 0.03), patients >10 years old (P = 2.2 × 10(-4)), and patients who had received more intensive chemotherapy regimen (P = 0.02). These results indicate that the incidence and risk factors in our institute were similar to those observed in Western countries. Future studies surveying the impact on the quality of life of childhood ALL survivors in Taiwan are warranted.

Entities:  

Mesh:

Year:  2015        PMID: 25840770     DOI: 10.1007/s12185-015-1790-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  Bony morbidity in children treated for acute lymphoblastic leukemia.

Authors:  A J Strauss; J T Su; V M Dalton; R D Gelber; S E Sallan; L B Silverman
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

2.  Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer.

Authors:  Marcus Jäger; Christoph Zilkens; Bettina Westhoff; Eva Maria Jelinek; Gordana Kozina; Rüdiger Krauspe
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

3.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

Authors:  L A Mattano; H N Sather; M E Trigg; J B Nachman
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

4.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

5.  Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.

Authors:  B Bernbeck; A Christaras; K Krauth; S Lentrodt; H Strelow; J Schaper; G Janssen; U Mödder; U Göbel
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

6.  Hypofibrinolysis, thrombophilia, osteonecrosis.

Authors:  C J Glueck; R A Freiberg; R N Fontaine; T Tracy; P Wang
Journal:  Clin Orthop Relat Res       Date:  2001-05       Impact factor: 4.176

7.  Hyperlipidaemia a risk factor for femoral head osteonecrosis (Legg-Calv -Perthes-like disease) in children with AIDS: case report.

Authors:  Paula Aguiar De Aragão; Renata B P Lemos; Maria Zilda Aquino; Heloisa Helena Souza Marques
Journal:  Braz J Infect Dis       Date:  2002-06       Impact factor: 1.949

8.  Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.

Authors:  Mary V Relling; Wenjian Yang; Soma Das; Edwin H Cook; Gary L Rosner; Michael Neel; Scott Howard; Raul Ribeiro; John T Sandlund; Ching-Hon Pui; Sue C Kaste
Journal:  J Clin Oncol       Date:  2004-10-01       Impact factor: 44.544

9.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

10.  Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.

Authors:  Nobuyuki Hyakuna; Yasuto Shimomura; Arata Watanabe; Takashi Taga; Atsushi Kikuta; Takeji Matsushita; Kazuhiro Kogawa; Chihiro Kawakami; Yasuo Horikoshi; Tsuyako Iwai; Yasuhiro Okamoto; Masahito Tsurusawa; Keiko Asami
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

View more
  2 in total

1.  Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study.

Authors:  Seung Min Hahn; Myeongjee Lee; Aaron Huser; Yeonji Gim; Eun Hwa Kim; Minsoo Kim; Amaal M Aldosari; Inkyung Jung; Yoon Hae Kwak
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

2.  British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.

Authors:  Nadia Amin; Sally Kinsey; Richard Feltbower; Jeannette Kraft; Elizabeth Whitehead; Mark Velangi; Beki James
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.